# Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia

> clinical trial · VERIFIED · 2026-06-16

Status: RECRUITING · Sponsor: Goethe University · Condition: T-ALL

- Company: Goethe University
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06648889

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.